Syndax Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 2 16:37 ET
Syndax Pharmaceuticals | DEF 14A: Definitive information statements
Apr 2 16:18 ET
Syndax Pharmaceuticals | DEFA14A: Others
Apr 2 16:05 ET
Syndax Pharmaceuticals | 8-K: Current report
Mar 18 07:14 ET
Syndax Pharmaceuticals | 10-K: Annual report
Feb 27 22:50 ET
Syndax Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Feb 27 17:32 ET
Syndax Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 27 17:28 ET
Syndax Pharmaceuticals | 8-K: Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
Feb 27 16:09 ET
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.
Feb 14 12:53 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%), etc.
Feb 14 07:06 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%), etc.
Feb 13 21:46 ET
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.11%)
Feb 13 17:27 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Metzger Michael A
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goldan Keith A.
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gallagher Neil
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Legault Pierre
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Podlesak Dennis
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Meury William
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Katkin Keith
Feb 9 16:06 ET
No Data
No Data